Congjun Zhang

752 total citations
48 papers, 594 citations indexed

About

Congjun Zhang is a scholar working on Computational Theory and Mathematics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Congjun Zhang has authored 48 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Computational Theory and Mathematics, 11 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Congjun Zhang's work include Optimization and Variational Analysis (12 papers), Contact Mechanics and Variational Inequalities (7 papers) and Fixed Point Theorems Analysis (6 papers). Congjun Zhang is often cited by papers focused on Optimization and Variational Analysis (12 papers), Contact Mechanics and Variational Inequalities (7 papers) and Fixed Point Theorems Analysis (6 papers). Congjun Zhang collaborates with scholars based in China, United States and Türkiye. Congjun Zhang's co-authors include Weiqiang Gong, Jinling Liang, Mengyue Hu, Jing Chen, Jun Li, Li Liu, Ye Zhang, Hong Bi, Guoping Sun and Wei Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Cancer Letters.

In The Last Decade

Congjun Zhang

46 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Congjun Zhang China 13 186 122 89 72 65 48 594
Longmei Li China 16 337 1.8× 95 0.8× 128 1.4× 65 0.9× 65 1.0× 40 689
Changchang Liu China 15 263 1.4× 149 1.2× 128 1.4× 83 1.2× 47 0.7× 50 784
Jiao Guan China 15 141 0.8× 91 0.7× 90 1.0× 51 0.7× 181 2.8× 41 697
Naga Rajiv Lakkaniga United States 15 234 1.3× 106 0.9× 30 0.3× 49 0.7× 35 0.5× 27 586
Jong-Kwang Kim South Korea 12 288 1.5× 61 0.5× 144 1.6× 33 0.5× 31 0.5× 39 590
Jianbing Wu China 13 280 1.5× 112 0.9× 89 1.0× 29 0.4× 24 0.4× 51 720
Jinmei Lai China 12 212 1.1× 60 0.5× 35 0.4× 75 1.0× 15 0.2× 120 666
Ben Morris United States 13 308 1.7× 91 0.7× 47 0.5× 20 0.3× 59 0.9× 34 703
Wenli Zhou China 15 216 1.2× 174 1.4× 28 0.3× 41 0.6× 160 2.5× 40 737
Shuhao Wang China 17 133 0.7× 160 1.3× 107 1.2× 54 0.8× 22 0.3× 65 1.1k

Countries citing papers authored by Congjun Zhang

Since Specialization
Citations

This map shows the geographic impact of Congjun Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congjun Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congjun Zhang more than expected).

Fields of papers citing papers by Congjun Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congjun Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congjun Zhang. The network helps show where Congjun Zhang may publish in the future.

Co-authorship network of co-authors of Congjun Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Congjun Zhang. A scholar is included among the top collaborators of Congjun Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congjun Zhang. Congjun Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Congjun, et al.. (2024). A retrospective study on the efficacy and safety of Envafolimab, a PD-L1 inhibitor, in the treatment of advanced malignant solid tumors. Frontiers in Pharmacology. 15. 1356013–1356013. 3 indexed citations
2.
Chen, Wenjun, et al.. (2023). Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance. Frontiers in Oncology. 13. 1053125–1053125. 11 indexed citations
3.
4.
Huang, Nana, Chenchen Zhao, Wei Huang, et al.. (2022). Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort. Annals of Translational Medicine. 10(6). 294–294. 8 indexed citations
5.
Huang, Nana, Chenchen Zhao, Congjun Zhang, et al.. (2022). Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors. Translational Cancer Research. 11(1). 252–261. 9 indexed citations
6.
Huang, Wei, et al.. (2022). Effectiveness and safety of camrelizumab combined with chemotherapy in nonsquamous nonsmall cell lung cancer as the second-line therapy. Journal of Cancer Research and Therapeutics. 18(2). 576–580. 6 indexed citations
7.
Zhang, Congjun, Shuangyan Ou, Yuan Zhou, et al.. (2021). m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer. Frontiers in Oncology. 11. 696371–696371. 31 indexed citations
8.
Liu, Hao & Congjun Zhang. (2020). Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2/prostaglandin E2 signaling pathway. Translational Cancer Research. 9(11). 7183–7195. 5 indexed citations
9.
Zhang, Congjun, et al.. (2020). Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis. Journal of Gastrointestinal Oncology. 11(6). 1155–1163. 12 indexed citations
10.
Zhan, Mengna, Yang Jiao, Yiyin Zhang, et al.. (2020). Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer. Cancer Letters. 493. 120–127. 15 indexed citations
11.
Ma, Qiang, et al.. (2020). Long Noncoding RNA PTPRG Antisense RNA 1 Reduces Radiosensitivity of Nonsmall Cell Lung Cancer Cells Via Regulating MiR-200c-3p/TCF4. Technology in Cancer Research & Treatment. 19. 1079210263–1079210263. 18 indexed citations
12.
Li, Xiaoqiu, Yangyang Zhao, Wei Jiang, et al.. (2019). Ultralong circulating choline phosphate liposomal nanomedicines for cascaded chemo-radiotherapy. Biomaterials Science. 7(4). 1335–1344. 15 indexed citations
13.
Chen, Wenjun, Xiaoqiu Li, Chenchen Zhao, et al.. (2019). Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation. Annals of Palliative Medicine. 8(5). 525–531. 11 indexed citations
14.
Zhang, Ying, et al.. (2018). The PD-1 rs36084323 A > G polymorphism decrease cancer risk in Asian: A meta-analysis. Pathology - Research and Practice. 214(11). 1758–1764. 13 indexed citations
15.
Pan, Zhipeng, Mengya Chen, Xingxing Hu, et al.. (2018). Associations between VDR gene polymorphisms and colorectal cancer susceptibility: an updated meta-analysis based on 39 case-control studies. Oncotarget. 9(16). 13068–13076. 18 indexed citations
16.
Zhang, Congjun, et al.. (2013). Gap Functions and Algorithms for Variational Inequality Problems. Journal of Applied Mathematics. 2013. 1–7. 1 indexed citations
17.
Zhang, Congjun, et al.. (2010). Strong convergence theorems for equilibrium problems and relatively nonexpansive mappings in Banach spaces. Computers & Mathematics with Applications. 61(2). 262–276. 7 indexed citations
18.
Zhang, Congjun, Jinlu Li, & Min Sun. (2006). Existence of Solutions for Abstract Economic Equilibrium Problems and Algorithm. Computers & Mathematics with Applications. 52(10-11). 1471–1482.
19.
Zhang, Congjun. (2005). Generalized Bi-Quasi-Variational Inequalities and Generalized Quasi-Variational Inequalities. 3 indexed citations
20.
Zhang, Congjun. (2002). A Class of Implicit Variational Inequalities with Applications to Nash Limitations Equilibrium Problem. Mathematica Applicata. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Longmei Li Breakdown of academic impact, for papers by Changchang Liu Breakdown of academic impact, for papers by Jiao Guan Breakdown of academic impact, for papers by Naga Rajiv Lakkaniga Breakdown of academic impact, for papers by Jong-Kwang Kim Breakdown of academic impact, for papers by Jianbing Wu Breakdown of academic impact, for papers by Jinmei Lai Breakdown of academic impact, for papers by Ben Morris Breakdown of academic impact, for papers by Wenli Zhou Breakdown of academic impact, for papers by Shuhao Wang
Rankless by CCL
2026